Information Provided By: 
Fly News Breaks for May 30, 2017
ATHN
May 30, 2017 | 07:13 EDT
UBS analyst Michael Cherny raised his price target on athenahealth to $152 from $123 to reflect the re-rating following the filing of a 13D by Elliott Associates. The filing created a broader discussion around the opportunity for a re-positioning following several quarters of challenged growth. He said the long-term earnings power remains intact, there is room for margin improvement, and multiple expansion based on operational improvements. Cherny reiterated his Buy rating on athenahealth shares.
News For ATHN From the Last 2 Days
There are no results for your query ATHN
